Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
基本信息
- 批准号:10844877
- 负责人:
- 金额:$ 5.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAffectAgingAgonistAlzheimer&aposs DiseaseAmino Acid TransporterAmino AcidsAstrocytesAttentionBrainBrain InjuriesCellsChronicCognitionComplexConsciousDementiaDendritic SpinesDiseaseEnzymesEventFemaleFlow CytometryFoundationsFunctional disorderGene TargetingGeneticGenetic TechniquesGlycineHigh Pressure Liquid ChromatographyHippocampusHumanHuntington DiseaseImaging TechniquesImmunohistochemistryImpaired cognitionInjuryInterventionJournalsKnockout MiceLearningLinkLong-Term PotentiationMediatingMemoryMicrogliaModelingMusN-Methyl-D-Aspartate ReceptorsNatural regenerationNeurobiologyNeurodegenerative DisordersNeurogliaNeuronsOutputParkinson DiseasePathologicPathologyPatientsPhasePhysiologic pulsePlayProcessProductionRecoveryRecovery of FunctionResearch PersonnelRoleSerineSignal TransductionSliceSourceSynapsesSynaptic TransmissionSynaptic plasticityTherapeuticTissuesTraumatic Brain InjuryTraumatic Brain Injury recoveryTraumatic injurybehavior testbrain cellbrain circuitrycentral nervous system injuryclinical investigationcognitive functionconditional knockoutconditioned fearexperimental studyextracellularhuman modelhuman tissueimproved outcomeinterdisciplinary approachlorismalemorris water mazemouse modelneuralneurotransmissionnovelnovel therapeuticsparent grantpharmacologicresponseserine racemasesynaptic functiontranscriptomics
项目摘要
Summary:
Human consciousness and cognitive function are governed by a complex brain circuitry made up of neural
connections regulated by an integrated multicellular network. Glial make up 90% of all cells in the brain and play
dynamic and active roles in neuronal signaling, where astrocytes and microglia regulate synaptic transmission
and plasticity. In the past decade, increasing evidence suggests that the principal co-agonist for N-methyl-D-
Aspartate receptors (NMDARs) is the D-amino acid, D-serine, rather than glycine; however, few studies have
examined its role in CNS pathologies. To address this gap, we have recently identified a novel mechanism of
synaptic damage, where glia within the tripartite synapse uniquely synthesize and release D-serine following the
onset of pathological events. We hypothesize that microglia are a key source of pathological D-serine that
hyperactivates extrasynaptic NMDAR subunits to initiate synaptic damage as a result of microglia targeting and
pruning of dendritic spines. Our proposed experiments will examine (1) the mechanisms of D-serine release from
microglia; (2) the mechanisms of synaptic damage and microglia targeting & pruning; (3) transcriptomic analysis
of brain injury in both murine and human models. We will achieve this by employing both genetic and
pharmacological approaches to dissect the mechanism of microglial action within the complexity of brain injury
using state-of-the-art transcriptomic, imaging, and genetic techniques. Our studies will result in a better
understanding of the mechanisms that regulate synaptic damage and dysfunction, but also will start to define
novel therapeutics for patient interventions.
概括:
人类的意识和认知功能由由神经组成的复杂脑电路支配
由集成的多细胞网络调节的连接。神经胶质占大脑中所有细胞的90%并发挥
星形胶质细胞和小胶质细胞调节突触传播的神经元信号传导中的动态和主动作用
和可塑性。在过去的十年中,越来越多的证据表明,N-甲基-D-的主要共同激动剂
天冬氨酸受体(NMDAR)是D-氨基酸,D-丝氨酸,而不是甘氨酸。但是,很少有研究
检查了其在CNS病理中的作用。为了解决这一差距,我们最近确定了一种新的机制
突触损伤,三方突触中的神经胶质独特地合成并释放了D塞林
病理事件的发作。我们假设小胶质细胞是病理性D丝氨酸的关键来源
过度激活外NMDAR亚基因小胶质细胞靶向和
树突刺修剪。我们提出的实验将检查(1)从
小胶质细胞; (2)突触损伤和小胶质细胞靶向和修剪的机制; (3)转录组分析
鼠和人类模型中的脑损伤。我们将通过使用遗传和
在脑损伤复杂性中剖析小胶质行为机制的药理方法
使用最先进的转录组,成像和遗传技术。我们的研究将导致更好
了解调节突触损伤和功能障碍的机制,但也将开始定义
用于患者干预的新型治疗学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Jon Liebl其他文献
Daniel Jon Liebl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Jon Liebl', 18)}}的其他基金
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10056316 - 财政年份:2017
- 资助金额:
$ 5.22万 - 项目类别:
Stabilizing the Tripartite Synaptic Complex Following TBI
TBI 后稳定三方突触复合体
- 批准号:
10581933 - 财政年份:2017
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7106557 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8105912 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
6966621 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8415579 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8215756 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8792874 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7597062 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8606255 - 财政年份:2005
- 资助金额:
$ 5.22万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
Stress Granule Formation in the Antiretroviral-Mediated Dysregulation of Oligodendrocyte Maturation in HIV-HAND
HIV-HAND 中抗逆转录病毒介导的少突胶质细胞成熟失调中的应激颗粒形成
- 批准号:
10762118 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations
选择性放射性核素输送以实现精确的骨髓生态位改变
- 批准号:
10727237 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
Mechanisms of Trypsin Activation in Pancreatitis
胰腺炎中胰蛋白酶激活的机制
- 批准号:
10587286 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别: